A cross-sectional analysis of joint status and quality of life in children and adolescents with haemophilia in Romania.
暂无分享,去创建一个
D. Poenaru | J. Pătrașcu | M. Serban | D. Mihailov | S. Arghirescu | C. Jinca | A. Diaconu | A. Trăilă | C. E. Ursu
[1] Adrienne Lee,et al. Individualized prophylaxis for optimizing hemophilia care: can we apply this to both developed and developing nations? , 2016, Thrombosis Journal.
[2] Y. T. van der Schouw,et al. Discontinuing early prophylaxis in severe haemophilia leads to deterioration of joint status despite low bleeding rates , 2016, Thrombosis and Haemostasis.
[3] J. Windyga. Is Continuous Low-Dose Prophylaxis Superior to On-Demand Treatment for Patients with Hemophilia? , 2016, Seminars in Thrombosis & Hemostasis.
[4] J. Oldenburg. Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens. , 2015, Blood.
[5] R. Ljung,et al. Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades , 2015, Haematologica.
[6] Y. Janu,et al. Joint Health Status of Hemophilia Patients in Jodhpur Region , 2015, Indian Journal of Hematology and Blood Transfusion.
[7] M. Ozelo,et al. Musculoskeletal evaluation in severe haemophilia A patients from Latin America , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[8] J. Gill,et al. The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia , 2013, British journal of haematology.
[9] R. Engelbert,et al. Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: Validity of the hemophilia joint health score , 2011, Arthritis care & research.
[10] G. Auerswald,et al. New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[11] J. Stonebraker,et al. A study of reported factor VIII use around the world , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.
[12] Alan R. Cohen,et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. , 2007, The New England journal of medicine.
[13] B. Feldman,et al. Hemophilia joint health score reliability study , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[14] P. Giangrande,et al. Clinical outcomes and resource utilization associated with haemophilia care in Europe , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[15] C. Kessler,et al. When should prophylactic treatment in patients with haemophilia A and B start?— The German experience , 1998, Haemophilia : the official journal of the World Federation of Hemophilia.
[16] H. Pettersson,et al. Haemophilia prophylaxis in young patients–a long‐term follow‐up , 1997, Journal of internal medicine.
[17] H. Pettersson,et al. Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B , 1992, Journal of internal medicine.